Vanberra Signal
Free trial

Eyenuk

Curated by Signal

AI based retinal image analysis for diabetic retinopathy

Life Sciences Technologyeyenuk.com

Overview

Developer of automated retinal image analysis for diabetic retinopathy. The flagship product EyeArt uses machine learning to analyze fundus images and detect lesions associated with diabetic retinopathy. Other products include EyeMark that tracks the progression of diabetic retinopathy, EyeSeeAMD for the diagnosis of age-related macular degeneration, and EyeApp, which is an app that combines a smartphone with a small imaging camera for mobile diagnosis of diabetic retinopathy.

Key facts

Founded
2010
Headquarters
Los Angeles, United States
Stage
Sign up to view
Industry
Life Sciences Technology

Business model

1 product or service
Sign up to view

Contact

Primary office
Sign up to view
Email
Sign up to view

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

  • GBSciences

    Developer of cannabinoid therapeutics for cardiovascular and other conditions

    Life Sciences TechnologyLas Vegas, United States

  • MobileDetectBIO

    Provider of mobile app and testing kits for the detection of COVID-19 ( SARS-CoV-2 )

    Life Sciences TechnologyStafford, United States

  • A&D Engineering

    Patient monitoring and weighing devices

    Life Sciences TechnologySan Jose, United States

About Eyenuk

What does Eyenuk do?

Developer of automated retinal image analysis for diabetic retinopathy.

Where is Eyenuk headquartered?

Eyenuk is headquartered in Los Angeles, United States.

When was Eyenuk founded?

Eyenuk was founded in 2010.

Which sector is Eyenuk in?

Eyenuk operates in Life Sciences Technology.

Who are Eyenuk's competitors?

Companies similar to Eyenuk include GBSciences, MobileDetectBIO, and A&D Engineering.